Proliferative Vitreoretinopathy Market Estimated to Exhibit 4.0 CAGR through 2018 to 2028
Fact.MR has announced the addition of the “ Proliferative Vitreoretinopathy Market ” : Global Industry Analysis and Opportunity Assessment, 2018 to 2018 to 2028" report to their offering. With the rise in emphasis on prevention and treatment of proliferative vitreoretinopathy (PVR), a serious ailment that leads to blindness despite repeated treatment, the requirement for vitreoretinal centers has gained importance worldwide. Prevention of PVR development at early stage RRD for preserving visual function in patients has become a primary agenda among medical researchers and clinicians. A recent Fact.MR analysis envisages the proliferative vitreoretinopathy market to reflect a modest 4.0% CAGR during the forecast period (2018-2027).? However, establishment of vitreoretinal centers for the provision of advanced ophthalmological procedures is considered impractical, on account of increasing social security costs – a key challenge faced by nations across the globe. In contrast...